SCHEMBL2183148

SCHEMBL2183148

CN(C)c1ccc(C(=O)c2cnc3c(ccn3[Si](C)(C)C(C)(C)C)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CNR2 P34972 2/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
HDAC4 P56524 2/20 0.33
P4HTM Q9NXG6 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3347458 0.80 MGAM (0.41) HPGDALDH1A1P4HTMLMNA
SCHEMBL3347936 0.80 PDGFRB (0.43) MAPTALDH1A1MEN1KMT2ATP53
SCHEMBL13004725 0.69
SCHEMBL3349807 0.69 PTGER4 (0.37) ALDH1A1
SCHEMBL2182346 0.67 HPGD (0.51) HPGDMAPTALDH1A1NPC1RAB9A
SCHEMBL13854152 0.67 MC4R (0.38) ALDH1A1MEN1KMT2ATP53CYP1A2
Michler'S Ketone SCHEMBL36517 0.66 ALDH1A1 (1.00) HPGDMAPTALDH1A1NPC1RAB9A
SCHEMBL274966 0.66 ALDH1A1 (1.00) HPGDMAPTALDH1A1NPC1RAB9A
SCHEMBL8944385 0.65
Michler'S Ketone SCHEMBL6566205 0.64 ALDH1A1 (0.95) HPGDMAPTALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166173-A1 3,5-DISUBSTUTUTED 1H-PYRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS EISAI CO., LTD. (JP) 2011-07-07 US disclosed
US-20110166173-A1 3,5-DISUBSTUTUTED 1H-PYRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS EISAI CO., LTD. (JP) 2011-07-07 US disclosed
WO-2005085244-A1 3,5-DISUBSTITUTED 1H-PZRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS EISAI LONDON RESEARCH LABORATORIES LIMITED (GB) 2005-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166173-A1 3,5-DISUBSTUTUTED 1H-PYRROLO [2,3-B] PYRIDINES AS JNK INHIBITORS API5, CDK5, MAPKAPK5 HPGD 981/4885MAPT 249/4885ALDH1A1 4027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.